Prognostic association between NLRP3 inflammasome expression level and operable pancreatic adenocarcinoma
Authors:
Open Access
- 9 June 2022
- journal article
- research article
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 37 (3) , 314-321
Abstract
Background: The NLRP3 inflammasome is significantly associated with tumor development and metastasis in various malignancies. However, the significance of the NLRP3 inflammasome in pancreatic adenocarcinoma has not been fully determined. Therefore, we try to evaluate the expression of the NLRP3 inflammasome in pancreatic adenocarcinoma and analyzed its prognostic significance. Methods: This cohort study enrolled 98 patients with primary pancreatic adenocarcinoma who received curative surgery. The NLRP3 inflammasome expression levels in cancer tissue were determined by immunohistochemistry, and compared with that of adjacent normal tissues. The association between NLRP3 inflammasome expression levels and baseline clinicopathological characteristics were also analyzed. Moreover, the correlation between NLRP3 inflammasome expression levels and survival was analyzed by log-rank test, and the survival curve was made by the Kaplan–Meier survival analysis. Results: Expression of each NLRP3 inflammasome component in cancer tissue was higher than that in the adjacent normal tissues (all P < 0.05), including NLRP3, IL-1β, ASC, and Caspase-1. All four components of the NLRP3 inflammasome were closely associated with clinical stage and lymph node status (all P < 0.05). The Kaplan–Meier log rank test showed that the high expression level of the NLRP3 inflammasome was significantly related to poor overall survival in pancreatic adenocarcinoma patients. Conclusions: NLRP3 inflammasome expression was upregulated in cancer tissue and closely associated with the prognosis of operable pancreatic adenocarcinoma.Keywords
This publication has 34 references indexed in Scilit:
- Molecular mechanisms regulating NLRP3 inflammasome activationCellular & Molecular Immunology, 2015
- Differential expression of inflammasomes in lung cancer cell lines and tissuesTumor Biology, 2015
- Pancreatic AdenocarcinomaNew England Journal of Medicine, 2014
- Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progressionLaboratory Investigation, 2014
- Inflammation and fatigue dimensions in advanced cancer patients and cancer survivorsCancer, 2012
- The Role of Chronic Inflammation: Chronic Pancreatitis as a Risk Factor of Pancreatic CancerDigestive Diseases, 2012
- VEGF and IL-18 in induced sputum of lung cancer patientsCytokine, 2011
- IL-18 Paradox in Pancreatic Carcinoma: Elevated Serum Levels of Free IL-18 are Correlated With Poor SurvivalJournal of Immunotherapy, 2009
- Immunobiology of the sentinel lymph node and its potential role for antitumour immunityThe Lancet Oncology, 2006
- Interleukin (IL)-18 may enhance Th1 response in early cancer but aggravate malignant disease in its later stagesMedical Hypotheses, 2005